| Line Item | 2026-03-10 | Y/Y |
|---|---|---|
| Revenue | $7.5M | — |
| Cost of Revenue | $5.6M | — |
| Gross Profit | $518K | — |
| R&D Expense | $363K | — |
| SG&A Expense | $2.4M | — |
| Operating Income | -$2.2M | — |
| Pre-tax Income | -$2.5M | — |
| Net Income | -$1.9M | — |
| EPS (Basic) | -$0.02 | — |
| EPS (Diluted) | -$0.02 | — |
| Line Item | 2026-03-10 | Y/Y |
|---|---|---|
| Cash & Equivalents | $43K | — |
| Accounts Receivable | $3.2M | — |
| Inventory | $112K | — |
| Current Assets | $6.8M | — |
| Total Assets | $26.9M | — |
| Current Liabilities | $13.1M | — |
| Long-term Debt | $1.1M | — |
| Total Liabilities | $15.1M |
| Line Item | 2026-03-10 | Y/Y |
|---|---|---|
| Operating Cash Flow | $101K | — |
| Capital Expenditures | $178K | — |
| Investing Cash Flow | -$178K | — |
| Financing Cash Flow | $889K | — |
| Free Cash Flow | -$77K | — |
| — |
| Stockholders' Equity | $8.8M | — |